Issues in Psychopharmacology (April)

Date of Issue: 04/01/2014 | Volume: 12 | Number: 4

Issue Links:Learning Objectives | Editorial Information

Teaser to be posted soon.

In This Issue


The Facts on Tardive Dyskinesia

Topics: Psychopharmacology Tips

We’re all aware that neuroleptics and other dopamine-receptor blocking agents (DRBAs) can cause a variety of movement disorders, often referred to as extrapyramidal syndromes (EPS).

Read More
Expert Q&A

Psychodynamic Psychopharmacology

David Mintz, MD, explains how psychodynamic psychopharmacology considers patients’ individuality in making treatment decisions.

Read More
Research Update

Has Research Found a Reliable Depression Biomarker in Boys?

Topics: Depressive Disorder | Research Updates

A major obstacle in the prevention of depression is the lack of a predictive biomarker in individuals who later develop the disorder. British researchers have shown that the combination of a physiological biomarker—salivary cortisol—and the presence of depressive symptoms might be used to predict the development of major depression in adolescents.

Read More
News of Note

Stem-Cell Research Reveals Differences in Bipolar Disorder Neurons

Topics: Bipolar Disorder | News of Note

A team of scientists from the University of Michigan Medical School studied a line of stem cells derived from patients with bipolar disorder to determine what, if any, differences could be found between these and the cells of people without the disorder.

Read More